Biomechatronics for designing bioprocess monitoring and control systems: Application to stem cell production

Journal of Biotechnology

Volumn 162, Issue 4, 2012, Pages 430-440

  Mandenius, Carl Fredrik ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Biomechatronics; Conceptual design; HESC cells; Hubka Eder model; PAT; Stem cell banks

Indexed keywords

BIO-MECHATRONICS; BIOMECHATRONIC; BIOPROCESS MONITORING; CELL BANKS; CELL MANUFACTURING; CELL PRODUCTION; CELL PRODUCTION SYSTEM; CELL PRODUCTS; DESIGN APPROACHES; DESIGN LAYOUT; DESIGN METHODOLOGY; DESIGN TOOL; HEPATOCYTES; HUMAN EMBRYONIC STEM CELLS; MONITORING AND CONTROL; MONITORING AND CONTROL SYSTEMS; MONITORING SYSTEM; PAT; PROCESS ANALYTICAL INSTRUMENTATION;

CHEMICAL SENSORS; CONCEPTUAL DESIGN; CONTROL SYSTEMS; PRODUCTION ENGINEERING;

STEM CELLS;

ANALYTICAL EQUIPMENT; ARTICLE; BIOMECHATRONICS; BIOPROCESS; CELL CULTURE; CONTROL SYSTEM; CONTROLLED STUDY; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; INSTRUMENTATION; LIVER CELL; MECHANICS; METHODOLOGY; MONITORING; PRIORITY JOURNAL; STEM CELL;

BIOENGINEERING; BIOTECHNOLOGY; CELL CULTURE TECHNIQUES; EMBRYONIC STEM CELLS; HEPATOCYTES; HUMANS;

EID: 84871641931     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2012.09.001     Document Type: Article

References (36)

1. Agarwal S., Holton K.L., Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008, 26:1117-1127.
2. Andersson H., Steel D., Asp J., Dahlenborg K., Jonsson M., Kågedal B., Jeppsson A., Lindahl A., Sartipy P., Mandenius C.F. Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells. Journal of Biotechnology 2010, 150:175-181.
3. Andrews P.W., et al. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Reviews 2009, 5:301-314.
4. Bachinger T., Riese U., Eriksson R., Mandenius C-F. Monitoring process states in a production scale CHO cell cultivation using a chemical multisensor array. Journal of Biotechnology 2000, 76:61-71.
5. Baradez M.O., Marshall D. The use of multidimensional image-based analysis to accurately monitor cell growth in 3D bioreactor culture. PLoS One 2011, 6(10):e26104. 10.1371/journal.pone.0026104.
6. Braam S.R., Passier R., Mummery C.L. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends in Pharmacological Sciences 2009, 30:536-545.
7. Brolén G., Sivertsson L., Björquist P., Eriksson G., Ek M., Semb H., Johansson I., Andersson T.B., Ingelman-Sundberg M., Heins N. Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. Journal of Biotechnology 2010, 145:284-294.
8. Chang K.H., Zandstra P.W. Quantitative screening of embryonic stem cell differentiation: endoderm formation as a model. Biotechnology and Bioengineering 2004, 88:287-298.
9. Derelöv M., Detterfelt J., Björkman M., Mandenius C.F. Engineering design methodology for bio-mechatronic products. Biotechnology Progress 2008, 24:232-244.
10. Dochain D., Perrier M. Dynamical modelling analysis, monitoring and control design for nonlinear bioprocesses. Advances in Biochemical Engineering/Biotechnology 1997, 56:147-197.
11. Douglas J.M. Conceptual Design of Chemical Processes 1988, McGraw-Hill, New York, USA.
12. Hubka V., Eder W.E. Design science. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Quality Guidelines Q5-Q10, 1998-2009 1996, Springer Verlag, Berlin, Germany.
13. Jensen J., Hyllner J., Björquist P. Human embryonic stem cell technology and drug discovery. Journal of Cellular Physiology 2009, 219:513-519.
14. Kanebratt K.P., Andersson T.B. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug Metabolism and Disposition: The Biological Fate of Chemicals 2008, 36:1444-1452.
15. Kunova M., Matulka K., Eiselleova L., Trckova P., Hampl A., Dvorak P. Development of humanized culture medium with plant-derived serum replacement for human pluripotent stem cells. Reproductive BioMedicine Online 2010, 21:676-686.
16. Mandenius C.F. Recent developments in monitoring, modelling and control of biological production systems. Bioprocess and Biosystems Engineering 2004, 26:347-351.
17. Mandenius C.F. Design of monitoring and sensor systems for bioprocesses by biomechatronic methodology. Chemical Engineering Technology 2012, 35(8):1412-1420. 10.1002/ceat. 201100553.
18. Mandenius C.F., Björkman M. Process analytical technology (PAT) and quality-by-design (QbD) aspects on stem cell manufacture. European Pharmaceutical Review 2009, 14:32-37.
19. Mandenius C.F., Björkman M. Design principles for biotechnology product development. Trends in Biotechnology 2010, 28:230-236.
20. Mandenius C.F., Björkman M. Biomechatronic Design in Biotechnology A Methodology for Development of Biotechnological Products 2011, John Wiley & Sons Inc, Hoboken, New Jersey, USA.
21. Mandenius C.F., Björkman M. Scale-up of bioreactors using biomechantronic design methodology. Biotechnology Journal 2012, 7:1026-1039. 10.1002/biot.201100463.
22. Mandenius C.F., Derelöv M., Detterfelt J., Björkman M. Process analytical technology and design science. European Pharmaceutical Review 2007, 12:74-80.
23. Mandenius C.F., Graumann K., Schultz T.W., Premsteller A., Olsson I.M., Periot E., Clemens C., Welin M. Quality-by-design (QbD) for biotechnology-related phamaceuticals. Biotechnology Journal 2009, 4:11-20.
24. Mandenius C.F., Andersson T.B., Alves P.M., Batzl-Hartmann C., Björquist P., Carrondo M.J.T., Chesne C., Coecke S., Edsbagge J., Fredriksson J.M., Gerlach J.C., Heinzle E., Ingelman-Sundberg M., Johansson I., Küppers-Munther B., Müller-Vieira U., Noor F., Zeilinger K. Towards preclinical predictive drug testing for metabolism and hepatotoxicity by in vitro models derived from human embryonic stem cells: a report on the Vitrocellomics EU-project. Alternatives to Laboratory Animals (ATLA) 2011, 39:147-171.
25. Pahl G., Beitz W. Engineering Design a Systematic Approach 1996, Springer Verlag, Berlin, Germany.
26. Ratcliffe E., Thomas R.J., Williams D.J. Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine. British Medical Bulletin 2011, 100:137-155.
27. Schmelzer E., Triolo F., Turner M.E., Thompson R.L., Zeilinger K., Reid L.M., Gridelli B., Gerlach J.C. Three-dimensional perfusion bioreactor culture supports differentiation of human fetal liver cells. Tissue Engineering Part A 2010, 16:2007-2016.
28. Seider W.D., Seader J.D., Lewin D.R. Process Design Principles 1999, John Wiley & Sons, New York, USA.
29. Sinz M., Wallace G., Sahi J. Current industrial practices in assessing CYP450 enzyme induction: Preclinical and clinical. American Association of Pharmaceutical Scientists Journal 2008, 10:391-400.
30. Stevens R., Brook P., Jackson K., Arnold S., Systems Engineering Coping with Complexity 1998, Prentice Hall, Harlow, UK.
31. Synnergren J., Heins N., Brolén G., Eriksson G., Lindahl A., Hyllner J., Olsson B., Sartipy P., Björquist P. Transcriptional profiling of human embryonic stem cells differentiating to definitive and primitive endoderm and further towards the hepatic lineage. Stem Cells Dev. 2010, 19:961-978.
32. Thomas R.J., Hourd P.C., Williams D.J. Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. Journal of Biotechnology 2008, 136:148-155.
33. Thomas R.J., Hope A.D., Hourd P., Baradez M., Miljan E.A., Sinden J.D., Williams D.J. Automated serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line. Biotechnology Letters 2009, 31:1167-1172.
34. Thomas R.J., Anderson D., Chandra A., Smith N.M., Young L.E., Williams D., Denning C. Automated scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnology and Bioengineering 2009, 102:1636-1644.
35. Ulrich K.T., Eppinger S.D. Product Design and Development 2007, McGraw-Hill, New York. 3rd ed.
36. United States' Food and Drug Administration (FDA) Guidance for Industry: PAT, A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance 2004, http://www.fda.gov/cvm/guidance/published.html.